Literature DB >> 3124187

The effect of haloperidol on cocaine self-administration is augmented with repeated administrations.

D C Roberts1, G Vickers.   

Abstract

Administration of haloperidol (0.075 mg/kg) prior to a 4-h self-administration session increases cocaine intake by male rats. Animals pretreated daily with haloperidol showed a significant augmentation of this response, with cocaine intake climbing from 37% above baseline to 65% above baseline in 7 days. Control rats given two treatments of haloperidol 7 days apart showed no augmentation of the response. This increased drug effect is unusual, since most behavioral actions of haloperidol in laboratory animals show tolerance. In humans, the antipsychotic activity of neuroleptic drugs requires many days to develop. Cocaine self-administration behavior might therefore provide a model for antipsychotic drug action.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3124187     DOI: 10.1007/bf00207247

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine.

Authors:  D C Roberts; M E Corcoran; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

2.  Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.

Authors:  N E Andén
Journal:  J Pharm Pharmacol       Date:  1972-11       Impact factor: 3.765

3.  Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

Authors:  H Asper; M Baggiolini; H R Burki; H Lauener; W Ruch; G Stille
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

4.  Pharmacology of neuroleptics upon repeated administration.

Authors:  I Moller Nielsen; B Fjalland; V Pedersen; M Nymark
Journal:  Psychopharmacologia       Date:  1974-01-11

5.  Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward.

Authors:  R A Yokel; R A Wise
Journal:  Science       Date:  1975-02-14       Impact factor: 47.728

6.  Differential effects of acute and chronic haloperidol treatment on striatal and nigral 3,4-dihydroxyphenylacetic acid (DOPAC) levels.

Authors:  E Meller; A J Friedhoff; E Friedman
Journal:  Life Sci       Date:  1980-02-18       Impact factor: 5.037

7.  Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.

Authors:  N M Nicolaou
Journal:  Eur J Pharmacol       Date:  1980-06-13       Impact factor: 4.432

8.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

9.  Reduced metabolic response of the rat brain to haloperidol after chronic treatment.

Authors:  G Pizzolato; T T Soncrant; D M Larson; S I Rapoport
Journal:  Brain Res       Date:  1985-06-24       Impact factor: 3.252

10.  Tolerance of haloperidol catalepsy.

Authors:  C Ezrin-Waters; P Seeman
Journal:  Eur J Pharmacol       Date:  1977-02-07       Impact factor: 4.432

View more
  8 in total

1.  Differential antagonism of cocaine self-administration and cocaine-induced disruptions of learning by haloperidol in rhesus monkeys.

Authors:  Peter J Winsauer; Joseph M Moerschbaecher; Alison M Roussell
Journal:  J Exp Anal Behav       Date:  2008-03       Impact factor: 2.468

2.  Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues.

Authors:  Anne-Marie Bédard; Jérôme Maheux; Daniel Lévesque; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

3.  Regulation of fat intake in the absence of flavour signalling.

Authors:  Jozélia G Ferreira; Luis A Tellez; Xueying Ren; Catherine W Yeckel; Ivan E de Araujo
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

Review 4.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

5.  Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats.

Authors:  Zheng-Xiong Xi; Jeremy G Gilbert; Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Eliot L Gardner
Journal:  Eur J Neurosci       Date:  2005-06       Impact factor: 3.386

6.  Flavor-independent maintenance, extinction, and reinstatement of fat self-administration in mice.

Authors:  Luis A Tellez; Jozelia G Ferreira; Sara Medina; Benjamin B Land; Ralph J DiLeone; Ivan E de Araujo
Journal:  Biol Psychiatry       Date:  2013-05-01       Impact factor: 13.382

7.  Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.

Authors:  Anne-Marie Bédard; Jérôme Maheux; Daniel Lévesque; Anne-Noël Samaha
Journal:  Schizophr Bull       Date:  2012-08-27       Impact factor: 9.306

Review 8.  Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?

Authors:  Gustavo A Angarita; Hasti Hadizadeh; Ignacio Cerdena; Marc N Potenza
Journal:  Expert Opin Pharmacother       Date:  2021-06-23       Impact factor: 4.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.